Patient info Search Menu

Lescol XL 80 mg prolonged-release tablets, Nandovar XL 80 mg prolonged-release tablets – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
No longer supplied
Medicine strength:
80 mg
Still supplied:
The same active substance, strength and form in the NHS Dictionary of Medicines and Devices (dm+d). Ask your pharmacist or doctor before changing to another make.
Contains active substance:

Patient leaflet - Lescol XL 80 mg prolonged-release tablets, Nandovar XL 80 mg prolonged-release tablets

1. What Lescol XL is and what it is used for

Lescol XL contains the active substance fluvastatin sodium which belongs to a group of medicines known as statins, which are lipid-lowering medicines: they lower the fat (lipids) in your blood. They are used in patients whose conditions cannot be controlled by diet and exercise alone.

  • Lescol XL is a medicine used to treat raised

    levels of fats in the blood in adults, in particular total cholesterol and so called “bad” or LDL cholesterol, which is associated with an increased risk of heart disease and stroke.

    • in adult patients with high blood levels of

      cholesterol

    • in adult patients with high blood levels of

      both cholesterol and triglycerides (another sort of blood lipid).

  • Your doctor can also prescribe Lescol XL to

    prevent further serious cardiac events (e.g. heart attack) in patients who have already had a heart catheterisation, with an intervention in the heart vessel.

If you have any questions about how Lescol XL works or why this medicine has been prescribed for you, ask your doctor.

2. What you need to know before you take Lescol XL

Follow all your doctor’s instructions carefully, even if they differ from the general information contained in this leaflet.

Read the following explanations before you take Lescol XL.

Do not take Lescol XL

  • if you are allergic (hypersensitive) to fluvastatin

    or any of the other ingredients of this medicine (listed in section 6).

  • if you currently have liver problems, or if you

    have unexplained, persistently high level of certain liver enzymes (transaminases).

  • if you are pregnant or breast-feeding

    (see “pregnancy and breast-feeding”). If any of these apply to you, do not take Lescol XL and tell your doctor.

Warnings and precautions

Talk to your doctor or pharmacist before taking Lescol XL.

  • if you are taking or have taken in the last 7 days

    a medicine called fusidic acid, (a medicine for bacterial infection) orally or by injection. The combination of fusidic acid and Lescol XL can lead to serious muscle problems

    (rhabdomyolysis).

  • if you previously had a liver disease. Liver

    function tests will normally be done before you start Lescol XL, when your dose is increased

    and at various intervals during treatment to check for side effects.

    • if you have a kidney disease.
    • if you have a thyroid disease (hypothyroidism).
    • if you have a medical history of muscle diseases

      yourself or in your family.

    • if you had muscle problems with another

      lipid-lowering medicine.

    • if you regularly drink large amounts of alcohol.

    • if you have a serious infection.
    • if you have very low blood pressure (signs may

      include dizziness, light-headedness).

    • if you have controlled or uncontrolled excessive

      muscle exercise.

    • if you are about to have an operation.
    • if you have severe metabolic, endocrine or

      electrolyte disorders such as decompensated diabetes and low blood potassium.

While you are on this medicine your doctor will monitor you closely if you have diabetes or are at risk of developing diabetes. You are likely to be at risk of developing diabetes if you have high levels of sugars and fats in your blood, are overweight and have high blood pressure.

Check with your doctor or pharmacist before taking Lescol XL:

  • if you have severe respiratory failure

If any of these apply to you, tell your doctor before taking Lescol XL. Your doctor will take a blood test before prescribing Lescol XL.

Also tell your doctor or pharmacist if you have a muscle weakness that is constant. Additional tests and medicines may be needed to diagnose and treat this.

If during treatment with Lescol XL, you develop symptoms or signs such as nausea, vomiting, loss of appetite, yellow eye or skin, confusion, euphoria or depression, mental slowing, slurred speech, sleep disturbance, tremors or easy bruising or bleeding, these may be signs of liver failure. In such case contact a doctor immediately.

This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially “sodium-free”.

Lescol XL and people over 70 years

If you are over 70 years your doctor may want to check if you have risk factors for muscular diseases. You may need specific blood tests.

Children and adolescents

Lescol XL has not been investigated and is not intended for the use in children below 9 years. For dose information in children and adolescents over 9 years, see section 3.

There is no experience with the use of fluvastatin in combination with nicotinic acid, cholestyramine or fibrates in children and adolescents.

Other medicines and Lescol XL

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines including medicines obtained without a prescription. If you need to take oral fusidic acid to treat a bacterial infection you will need to temporarily stop using Lescol XL. Your doctor will tell you when it is safe to restart Lescol XL. Taking Lescol XL with fusidic acid may rarely lead to muscle weakness, tenderness or pain (rhabdomyolysis). See more information regarding rhabdomyolysis in section 4.

Lescol XL can be taken on its own or with other cholesterol-lowering medicines prescribed by your doctor.

After intake of a resin, e.g. cholestyramine (primarily used to treat high cholesterol) wait at least 4 hours before taking Lescol XL.

Tell your doctor and pharmacist if you are taking any of the following:

  • Ciclosporin (a medicine used to suppress the

    immune system).

  • Fibrates (e.g. gemfibrozil), nicotinic acid or bile

    acid sequestrants (medicines used to lower bad cholesterol levels).

  • Fluconazole (a medicine used to treat fungal

    infections).

    • Rifampicin (an antibiotic).
    • Phenytoin (a medicine used to treat epilepsy).
    • Oral anticoagulants like warfarin (medicines used to reduce blood clotting).
    • Glibenclamide (a medicine used to treat diabetes).
    • Colchicines (used to treat gout).

Pregnancy and breast-feeding

Do not take Lescol XL if you are pregnant or breast-feeding as the active ingredient may lead to harm to your unborn child, and it is not known whether the active ingredient is excreted in human breast milk.

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Take adequate precaution against pregnancy while taking Lescol XL.

If you become pregnant while taking this medicine, stop taking Lescol XL and see your doctor. Your doctor will discuss with you the potential risk of taking Lescol XL during pregnancy.

Driving and using machines

There is no information on the effects of Lescol XL on your ability to drive and use machines.

3. How to take Lescol XL

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Do not exceed the recommended dose.

Your doctor will recommend you to follow a low-cholesterol diet. Stay on this diet while taking Lescol XL.

How much Lescol XL to take

The dose range of fluvastatin for adults is 20 to 80 mg per day and depends on the extent of cholesterol lowering which needs to be achieved. Dose adjustments may be made by your doctor at 4-week or longer intervals.

Use in children and adolescents

For children (aged 9 years and older) the usual starting dose is 20 mg of fluvastatin per day. The maximum daily dose is 80 mg. Dose adjustments may be made by your doctor at 6-week intervals. Your doctor will tell you exactly how much fluvastatin to take.

Depending on how you respond to the treatment, your doctor may suggest a higher or lower dose. When to take Lescol XL

If you are taking Lescol XL tablets you can take your dose at any time of the day.

Lescol XL can be taken with or without meals. Swallow whole with a glass of water.

If you take more Lescol XL than you should

If you have accidentally taken too many tablets of Lescol XL, talk to your doctor straight away. You may need medical attention.

If you forget to take Lescol XL

Take one dose as soon as you remember. However, do not take it if there is less than 4 hours before your next dose. In this case take your next dose at the usual time.

Do not take a double dose to make up for a forgotten dose.

If you stop taking Lescol XL

To maintain the benefits of your treatment, do not stop taking Lescol XL unless your doctor tells you to. You must continue to take Lescol XL as directed to keep the levels of your ‘bad’ cholesterol down. Lescol XL will not cure your condition but it does help control it. Your cholesterol levels need to be checked regularly to monitor your progress. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. Some rare (may affect up to 1 in 1,000 people) or very rare (may affect up to 1 in 10,000 people) side

! PLEASE TURN OVERPRINTING ON !

effects could be serious: get medical help immediately.

  • if you have unexplained muscle pain,

    tenderness or weakness. These might be early signs of a potentially severe muscle degradation. This can be avoided if your doctor stops your treatment with fluvastatin as quickly as possible. These side effects have also been found with similar medicines of this class (statins).

  • if you have unusual tiredness or fever, yellowing

    of the skin and eyes, dark coloured urine (signs of hepatitis).

  • if you have signs of skin reactions such as skin

    rash, hives, redness, itching, swelling of the face, eyelids, and lips.

  • if you have skin swelling, difficulty in breathing,

    dizziness (signs of severe allergic reaction).

  • if you bleed or bruise more easily than normal

    (signs of decreased number of blood platelets).

  • if you have red or purple skin lesions (signs of

    blood vessel inflammation).

  • if you have red blotchy rash mainly on the face

    which may be accompanied by fatigue, fever, nausea, loss of appetite (signs of lupus erythematous-like reaction).

  • if you have severe upper stomach pain (signs of

    inflamed pancreas).

If you experience any of these, tell your doctor straight away.

Other side effects: tell your doctor if they worry you. Common (may affect up to 1 in 10 people): Difficulty in sleeping, headache, stomach discomfort, abdominal pain, nausea, abnormal blood test values for muscle and liver.

Very rare (may affect up to 1 in 10,000 people): Tingling or numbness of the hands or feet, disturbed or decreased sensitivity.

Not known (frequency cannot be estimated from the available data):

  • Impotence, muscle weakness that is constant,

    breathing problems including persistent cough and/or shortness of breath or fever.

  • Diarrhoea.

Other possible side effects

  • Sleep disturbances, including insomnia and

    nightmares

  • Memory loss
  • Sexual difficulties
  • Depression
  • Diabetes. This is more likely if you have high

    levels of sugars and fats in your blood, are overweight and have high blood pressure. Your doctor may monitor you while you are taking this medicine.

  • Inflammation, swelling, and irritation of a

    tendon.

If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Lescol XL

  • Keep this medicine out of the sight and reach of

    children.

  • Do not use this medicine after the expiry date

    which is stated on the pack. The expiry date refers to the last day of that month.

  • Do not store Lescol XL tablets above 30°C.

    Store in the original package in order to protect from moisture.

  • Do not use this medicine if you notice that the

    pack is damaged or shows signs of tampering.

  • Leave your Lescol XL tablet in the blister pack

    until required for use, in order to protect from moisture.

  • Do not throw away any medicines via

    wastewater or household waste. Ask your pharmacist how to throw away medicines you

    no longer use. These measures will help to protect the environment.

6. Contents of the pack and other information

What Lescol XL contains

  • The active substance is fluvastatin sodium.

    Each Lescol XL 80 mg tablet contains 84.24 mg of fluvastatin sodium equivalent to 80 mg fluvastatin free acid.

  • The other ingredients of Lescol XL 80 mg tablets are: cellulose microcrystalline, hypromellose, hydroxypropyl cellulose, potassium hydrogen carbonate, povidone, magnesium stearate, macrogol 8000, iron oxide yellow (E172), titanium dioxide (E 171).

What Lescol XL looks like and contents of the pack

  • Lescol XL 80 mg prolonged-release tablets are yellow, round, slightly biconvex with bevelled edges. They have the letters “LE” on one side and “NVR” on the other.
  • Bottles: The prolonged-release tablets are supplied in packs of 28, 30, 50, 98 or 100 (2 x 50 or 1 x 100) tablets and in hospital packs of 300 (15 x 20) or 600 (30 x 20) tablets.
  • Blisters: The prolonged-release tablets are supplied in packs of 7, 14, 28 (4 x 7 or 2 x 14), 28 (in a perforated unit dose blister), 30, 42, 49 (7 x 7), 56 (8 x 7), 70, 84, 90 or 98 (14 x 7 or 7 x 14) tablets and in hospital packs of 28, 56, 98 or 490 tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:

Marketing Authorisation Holder

Novartis Ireland Limited,

Vista Building,

Elm Park, Merrion Road,

Ballsbridge,

Dublin 4,

Ireland.

Manufacturer

Novartis Pharmaceuticals UK Limited,

2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane,

London,

W12 7FQ

United Kingdom.

Novartis Pharma GmbH

Roonstrasse 25

90429 Nürnberg

Germany

If you would like any more information, or would like this leaflet in a different format, please contact Medical Information at Novartis Pharmaceuticals UK Ltd, telephone number 01276 698370. This leaflet was last revised in July 2021.

1972351 GB

! PLEASE TURN OVERPRINTING ON !

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk)

Last revision stated in the text: July 2021

What the sections and the side effect frequencies mean: How to read a patient leaflet

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Lescol XL 80 mg prolonged-release tablets, Nandovar XL 80 mg prolonged-release tablets

What these facts mean

Active substance? Fluvastatin
Strength? 80 mg
Pharmaceutical form? Modified-release tablet
How is it taken? Oral
Is it available?? No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)?
  1. C Cardiovascular system drugs
    1. C10 Lipid modifying agents
      1. C10A Lipid modifying agents, plain
        1. C10AA HMG CoA reductase inhibitors, plain lipid modifying drugs
          1. C10AA04 fluvastatin
Marketing authorisation? PL 23860/0015
Codes? BNF 02120000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 11.1.0 of 9 November 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.